Consistent with this, GSK-3β inhibition has been shown to reduce Aβ production in Alzheimer’s disease murine models, and to lessen Aβ-induced neurotoxicity in cultured neurons [53,54,55]. Here, GSK3B is linked to Alzheimer disease.